Literature DB >> 3123068

Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells.

J F Wedgwood1, L Hatam, V R Bonagura.   

Abstract

The expression of class I and class II major histocompatibility complex (MHC) molecules on the surface of cultured human umbilical vein endothelial cells (HUVEC) incubated with alpha tumor necrosis factor (TNF) or interferon-gamma (IFN-gamma) was determined by fluorescence flow cytometry. HUVEC were stained with fluorescein conjugated monoclonal antibodies (MoAbs) directed against monomorphic determinants of class I MHC molecules, HLA-A, B alpha chain (HLA-alpha) and beta-2-microglobulin (B2m), and class II MHC molecules, HLA-DR and HLA-DQ. HUVEC exposed to TNF for 96 hr increase their expression of class I MHC molecules two- to fourfold. Similarly, IFN-gamma increases the expression of class I MHC molecules two- to fivefold. No induction of HLA-DR or HLA-DQ was seen following exposure to TNF. IFN-gamma induces the appearance and markedly increases the expression of HLA-DR following 96 hr incubation. HLA-DQ was also induced by IFN-gamma but to a much lesser extent. TNF in combination with IFN-gamma enhances HUVEC expression of HLA-alpha, B2m, and HLA-DQ greater than that observed with either mediator alone. TNF and IFN-gamma reduced HUVEC expression of HLA-DR below the level observed with IFN-gamma alone. Indomethacin (INDO) does not effect expression of HUVEC class I or class II MHC molecules induced by TNF, IFN-gamma, or the combination of these mediators. These immune mediators produce unique and common effects on HUVEC, and therefore may act by at least two separate mechanisms, independent of the cyclooxygenase pathway, which regulate HUVEC expression of class I and class II MHC surface molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123068     DOI: 10.1016/0008-8749(88)90046-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

Review 1.  Tumor necrosis factor regulation of major histocompatibility complex gene expression.

Authors:  D R Johnson; J S Pober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.

Authors:  D Leszczynski
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

Review 3.  Cytokine research: the interferon paradigm.

Authors:  A Morris; I Zvetkova
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 4.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

Review 5.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

6.  Different microvascular endothelial cell phenotypes exhibit different class I and II antigens under interferon-gamma.

Authors:  K Spanel-Borowski; G Bein
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-08       Impact factor: 2.416

7.  Interactions of interferons in the induction of histocompatibility antigens in mouse fibroblasts and glial cells.

Authors:  A G Morris; P T Tomkins
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

8.  Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha.

Authors:  K Adachi; P Belser; H Bender; D Li; U Rodeck; E N Benveniste; D Woo; W H Schmiegel; D Herlyn
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Agents Actions       Date:  1994-10

10.  Lipopolysaccharide augments HLA-A,B,C molecule expression but inhibits interferon-gamma-induced HLA-DR molecule expression on cultured human endothelial cells.

Authors:  A Otsuka; T Hanafusa; N Kono; S Tarui
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.